Schubert & Co Has $506,000 Stock Holdings in Procter & Gamble Company (The) $PG

Schubert & Co grew its position in Procter & Gamble Company (The) (NYSE:PG) by 4.3% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,175 shares of the company’s stock after purchasing an additional 131 shares during the period. Schubert & Co’s holdings in Procter & Gamble were worth $506,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Kingstone Capital Partners Texas LLC boosted its stake in shares of Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Northern Trust Corp lifted its position in Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after buying an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after buying an additional 583,629 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Procter & Gamble by 6.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after buying an additional 1,018,865 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling

In other news, CEO Jon R. Moeller sold 11,684 shares of the company’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $1,778,655.32. Following the completion of the sale, the chief executive officer directly owned 319,932 shares of the company’s stock, valued at $48,703,248.36. This represents a 3.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Jennifer L. Davis sold 3,227 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the completion of the sale, the chief executive officer directly owned 61,764 shares of the company’s stock, valued at approximately $9,402,333.72. This trade represents a 4.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock worth $23,421,279 over the last quarter. Insiders own 0.20% of the company’s stock.

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $151.53 on Friday. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The company has a market cap of $354.66 billion, a PE ratio of 23.28, a PEG ratio of 4.02 and a beta of 0.36. The company’s 50-day moving average is $154.92 and its two-hundred day moving average is $158.77. Procter & Gamble Company has a 1 year low of $146.96 and a 1 year high of $180.43.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.Procter & Gamble’s revenue was up 1.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be paid a $1.0568 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble’s dividend payout ratio is 64.98%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Evercore ISI reiterated an “in-line” rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. Wells Fargo & Company reduced their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Barclays cut their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Finally, JPMorgan Chase & Co. cut their target price on shares of Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a research report on Friday, October 10th. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $172.21.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.